The impact of MDR1 polymorphisms on prolactin concentrations in patients treated with risperidone

A.F. Al Hadithy^*, B. Wilffert, R. Bruggeman, J.R. Brouwers

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	593-594
Number of pages	2
Journal	Progress in Neuro-Psychopharmacology & Biological Psychiatry
Volume	32
Issue number	2
DOIs	https://doi.org/10.1016/j.pnpbp.2007.10.019
Publication status	Published - 15-Feb-2008

Access to Document

The impact of MDR1 polymorphisms on prolactin concentrations in patients
Final publisher's version, 96.3 KB
Request copy

@article{c347e479ad8748a0ade04100aa04be63,

title = "The impact of MDR1 polymorphisms on prolactin concentrations in patients treated with risperidone",

author = "{Al Hadithy}, A.F. and B. Wilffert and R. Bruggeman and J.R. Brouwers",

year = "2008",

month = feb,

day = "15",

doi = "10.1016/j.pnpbp.2007.10.019",

language = "English",

volume = "32",

pages = "593--594",

journal = "Progress in Neuro-Psychopharmacology & Biological Psychiatry",

issn = "0278-5846",

publisher = "PERGAMON-ELSEVIER SCIENCE LTD",

number = "2",

}

TY - JOUR

T1 - The impact of MDR1 polymorphisms on prolactin concentrations in patients treated with risperidone

AU - Al Hadithy, A.F.

AU - Wilffert, B.

AU - Bruggeman, R.

AU - Brouwers, J.R.

PY - 2008/2/15

Y1 - 2008/2/15

U2 - 10.1016/j.pnpbp.2007.10.019

DO - 10.1016/j.pnpbp.2007.10.019

M3 - Comment/Letter to the editor

SN - 0278-5846

VL - 32

SP - 593

EP - 594

JO - Progress in Neuro-Psychopharmacology & Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology & Biological Psychiatry

IS - 2

ER -